These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8144102)

  • 1. [Effects of pranidipine (OPC-13340), a novel 1,4-dihydropyridine derivative Ca-antagonist, on isolated porcine coronary contraction and acute myocardial ischemia in the pig].
    Ohura M; Mori T; Watanabe K; Ikezono K; Nakayama N; Tominaga M; Yabuuchi Y
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):101-9. PubMed ID: 8144102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.
    Takeuchi K; Omura T; Yoshiyama M; Yoshida K; Otsuka R; Shimada Y; Ujino K; Yoshikawa J
    Heart Vessels; 1999; 14(3):111-9. PubMed ID: 10776803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of palonidipine hydrochloride (TC-81), a new dihydropyridine derivative, on various myocardial ischemic models].
    Kishimoto T; Okamiya Y; Aoki K; Ota M; Hoshina K; Takeshita T
    Nihon Yakurigaku Zasshi; 1993 Aug; 102(2):85-100. PubMed ID: 8370558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.
    Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y
    Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
    Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
    Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.
    Mori T; Takase H; Toide K; Hirano T; Kambe T; Nakayama N; Schwartz A
    Cardiovasc Drug Rev; 2001; 19(1):1-8. PubMed ID: 11314598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pranidipine, a calcium channel antagonist, in an avian model of heart failure.
    Kim CS; Matsumori A; Goldberg L; Doye AA; McCoy Q; Gwathmey JK
    Cardiovasc Drugs Ther; 1999 Sep; 13(5):455-63. PubMed ID: 10547227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pranidipine enhances relaxation produced by endothelium-derived relaxing factor in carotid artery.
    Koshita M; Takano H; Nakahira Y; Suzuki H
    Eur J Pharmacol; 1999 Dec; 385(2-3):191-7. PubMed ID: 10607875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of nitrendipine on cardiovascular systems].
    Kawahara K; Satoh H; Inui J
    Nihon Yakurigaku Zasshi; 1988 Dec; 92(6):397-410. PubMed ID: 3250917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.
    Fujisawa M; Yorikane R; Matsuoka Y; Koike H; Ueno K
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):63-9. PubMed ID: 23288106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine.
    Dubé GP; Baik YH; Schwartz A
    J Cardiovasc Pharmacol; 1985; 7(2):377-89. PubMed ID: 2581094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
    Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of the systemic hemodynamics and myocardial oxygen consumption of FRC 8653, a new Ca++ channel blocker, and nifedipine in anesthetized dogs.
    Chibana T; Noguchi K; Ojiri Y; Sakanashi M
    Jpn Heart J; 1992 Mar; 33(2):239-52. PubMed ID: 1593752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
    Hirano T; Ohura M; Orito K; Fujiki H; Miyakoda G; Mori T
    Eur J Pharmacol; 1997 Apr; 324(2-3):201-4. PubMed ID: 9145772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro.
    Nakayama N; Ikezono K; Ohura M; Yabuuchi Y
    Arzneimittelforschung; 1993 Dec; 43(12):1266-70. PubMed ID: 8141812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of azelnidipine, a dihydropyridine calcium antagonist, on myocardial stunning in dogs.
    Satoh K; Yamamoto A; Hoshi K; Ichihara K
    Jpn J Pharmacol; 1998 Apr; 76(4):369-76. PubMed ID: 9623715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs.
    Moriyama T; Karasawa A
    Biol Pharm Bull; 1994 Nov; 17(11):1468-71. PubMed ID: 7703965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of efonidipine hydrochloride, a calcium antagonist derived from dihydropyridine, on acute myocardial ischemia in anesthetized open-chest dogs].
    Yokoyama T; Fujikura N; Masuda Y; Shikada K; Tanaka S
    Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):307-21. PubMed ID: 9017685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pranidipine, a novel calcium channel antagonist, on the progression of left ventricular dysfunction and remodeling in rats with heart failure.
    Wahed MI; Watanabe K; Ma M; Nakazawa M; Takahashi T; Hasegawa G; Naito M; Yamamoto T; Kodama M; Aizawa Y
    Pharmacology; 2004 Sep; 72(1):26-32. PubMed ID: 15292652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
    Nakaya H; Hattori Y; Nakao Y; Kanno M
    Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.